English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
Multi-targeted therapies for cancer treatment
Share :
AORTIC
13 Dec 2011
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
8 Jan 2010
Views:
14738
Rating:
Save
Rate video
Dr Waldemar Szpak - Durban, South Africa
Dr Waldemar Szpak talks about multi-targeted therapy for cancer treamtent and the cost of drugs in developing countries.
This filming was supported by an unrestricted grant from Pfizer Oncology.
Categories:
Drug development
Related Videos
Pembrolizumab improves breast cancer outcomes regardless of age or menopausal...
Dr Javier Cortes - International Breast Cancer Center, Barcelona, Spain
26 Mar 2024
Using AI to identify patients at increased risk of side effects from radiation...
Dr Tim Rattay - University of Leicester Cancer Research Centre, Leicester, UK
25 Mar 2024
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale...
25 Mar 2024
Optimising multiple myeloma care in Latin America
Dr David Gómez-Almaguer - Autonomous University of Nuevo León, Monterrey, Mexico
6 Mar 2024
Multiple myeloma in a resource constrained setting
Dr Henry Ddungu - Uganda Cancer Institute, Kampala, Uganda
22 Feb 2024
Nab-paclitaxel as first line treatment of gastrointestinal neuroendocrine...
Dr Lorraine Chantrill - University of Sydney, Sydney, Australia
9 Feb 2024
Trifluridine/tipiracil and bevacizumab combination gives a prolonged PFS...
Prof Hironaga Satake - Kochi Medical School, Kochi, Japan
8 Feb 2024
ASCO GU 2024: Current best practice for mRCC
Prof Jens Bedke, Prof Thomas Powles, Prof Michael Staehler and Dr Wenxin Xu
1 Feb 2024
Updates on lung cancer from WCLC and ESMO 2023
Dr Luis Raez - Memorial Cancer Institute, Miami, USA
31 Jan 2024
More from
e
cancer